Furthermore, the modulation of vtRNA2-1 and vtRNA1-3 was previously associated with human bone marrow CD34+ cells, AML and MDS (Helboet al., 2015;Treppendahlet al., 2012). Here, CD34 is linked to myelodysplastic syndrome.